Arexvy overview
What Arexvy is used for [1]
Arexvy is a vaccine that helps to protect adults aged 18 years and older against a virus called ‘respiratory syncytial virus’ (RSV).
RSV is a respiratory virus that spreads very easily.
- RSV can cause lower respiratory tract disease - infections of the lungs and other parts of the body that help you breathe.
RSV infection usually causes mild, cold-like signs in healthy adults. But it can also:- cause more serious respiratory illnesses and complications, such as infections of the lungs (pneumonia), in older adults and adults with underlying medical conditions
- make some illnesses worse, such as long-term respiratory or heart diseases.
How Arexvy works
Arexvy helps your body’s natural defences make antibodies and special white blood cells. These protect you against RSV.
Arexvy does not contain the virus. This means it cannot cause an infection.
Arexvy is given to:
- adults 18 years and above;
How Arexvy is given
- Arexvy is given as a single dose injection of 0.5 mL into a muscle. It is usually given into the upper arm'. 'If you have any further questions on the use of this medicine, ask your doctor, practice nurse or pharmacist.
▼ This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. See the end of section 4 for how to report side effects
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed on this website or in the product package leaflet. You can also report side effects directly to HPRA Pharmacovigilance on their website: www.hpra.ie. By reporting side effects, you can help provide more information on the safety of this medicine.
Arexvy is a registered trademark of the GlaxoSmithKline group of companies.
